. Overall cellularity of the cerebral cortex is not affected by p73 knock-out or by specific blockage of the p300/β-catenin interaction. Cellularity was calculated as the number of DAPI+ nuclei under 90 µ m wide cortical column. E13.5 p73 wild type (WT) and knock-out (KO) embryos treated for 4 days with DMSO present with cellularity similar to E13.5 p73 WT and KO embryos treated with CBP/catenin antagonist ICG-001 for 4 days (A). E12.5 embryos treated for 3 days with DMSO, ICG-001, p300/catenin antagonist IQ-1, p300/catenin antagonist YH249 or both YH249 and ICG-001 (Rescue YH) show similar cellularity (B). n ≥ 6. Figure S2 . p73 knock-out mouse embryos show an increase in the CBP/β-catenin interaction. Numerical values above bands indicate densitometric quantitation normalized to background (Ctl IP) for each treatment condition and then normalized to WT DMSO for CBP IP or p300 IP.
. Overall cellularity of the cerebral cortex is not affected by p73 knock-out or by specific blockage of the p300/β-catenin interaction. Cellularity was calculated as the number of DAPI+ nuclei under 90 µ m wide cortical column. E13.5 p73 wild type (WT) and knock-out (KO) embryos treated for 4 days with DMSO present with cellularity similar to E13.5 p73 WT and KO embryos treated with CBP/catenin antagonist ICG-001 for 4 days (A). E12.5 embryos treated for 3 days with DMSO, ICG-001, p300/catenin antagonist IQ-1, p300/catenin antagonist YH249 or both YH249 and ICG-001 (Rescue YH) show similar cellularity (B). n ≥ 6. Figure S4 . Prematurely enhanced neurogenic commitment observed with p300/catenin antagonist IQ-1 treatment is reversed by co-administration of CBP/catenin antagonist ICG-001. Quantification of Tis21-GFP+ cells as a measure of neurogenic commitment. Embryos were treated for 3 days with DMSO, CBP/catenin antagonist ICG-001, full or half dose of p300/catenin antagonist IQ-1 or IQ-1 and ICG-001 (Rescue IQ-1 half). Sections were stained for GFP and NeuN. The percentage of Tis21-GFP+ cells in the ventricular zone was calculated as the number of GFP+ within the NeuN-negative zone. One-way ANOVA followed by Newman-Keuls multiple comparison test showing significant differences between ICG-001 and both IQ-1 conditions, as well as between the rescue condition and both IQ-1 conditions. vz, ventricular zone. n ≥ 3. 
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